EOJOAM
OCUL icon

E. Ohman J:or Asset Management’s Ocular Therapeutix OCUL Stock Holding History

E. Ohman J:or Asset Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Buy
385,000
+85,000
+28% +$770K 0.09% 119
2026
Q1 		$2.54M Buy
+300,000
New +$2.86M 0.07% 154

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

E. Ohman J:or Asset Management's OCUL Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Ocular Therapeutix (OCUL) stake by 28% in Q2 2026, buying an estimated $770K and bringing the position to 385,000 shares worth $3.78M. The position accounts for 0.09% of the portfolio, ranked #119.

E. Ohman J:or Asset Management first reported a position in OCUL in Q1 2026 and has held it in 2 quarters since. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • E. Ohman J:or Asset Management held 385,000 shares of Ocular Therapeutix worth $3.78M as of Q2 2026.
  • E. Ohman J:or Asset Management bought 85,000 Ocular Therapeutix shares in Q2 2026, an estimated $770K.
  • Ocular Therapeutix made up 0.09% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #119 holding.
  • E. Ohman J:or Asset Management first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 2 quarters since.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.